Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories Management to Present at June Conferences

WILMINGTON, Mass.--(BUSINESS WIRE)--May 24, 2004--Charles River Laboratories International, Inc. (NYSE:CRL) announced today that Management will present at two conferences in June 2004.

On Wednesday, June 9th, at 9:00 a.m. PDT, Chairman, President and Chief Executive Officer James C. Foster will present at the Pacific Growth Equities Life Sciences Growth Conference in San Francisco, CA.

On Thursday, June 10th at 9:40 a.m. PDT, Mr. Foster will present at the Goldman Sachs 25th Annual Global Healthcare Conference in Dana Point, CA.

A live webcast of each presentation will be available through links that will be posted on the Investor Relations section of the Charles River Laboratories website, http://ir.criver.com. A webcast replay for each conference will be accessible through the same website approximately three hours after the presentation and will remain available for one week from the date of the presentation.


    CONTACT: Charles River Laboratories International, Inc.
             Susan E. Hardy, 978-658-6000 ext.1616

    SOURCE: Charles River Laboratories International, Inc.

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)